TBHQ Attenuates Neurotoxicity Induced by Methamphetamine in the VTA through the Nrf2HO-1 and PI3KAKT Signaling Pathways

Abstract EN

Methamphetamine (METH) leads to nervous system toxicity.

Long-term exposure to METH results in damage to dopamine neurons in the ventral tegmental area (VTA), and depression-like behavior is a clinical symptom of this toxicity.

The current study was designed to investigate whether the antioxidant tertiary butylhydroquinone (TBHQ) can alleviate neurotoxicity through both antioxidative stress and antiapoptotic signaling pathways in the VTA.

Rats were randomly divided into a control group, a METH-treated group (METH group), and a METH+TBHQ-treated group (METH+TBHQ group).

Intraperitoneal injections of METH at a dose of 10 mg/kg were administered to the rats in the METH and METH+TBHQ groups for one week, and METH was then administered at a dose that increased by 1 mg/kg per week until the sixth week, when the daily dosage reached 15 mg/kg.

The rats in the METH+TBHQ group received 12.5 mg/kg TBHQ intragastrically.

Chronic exposure to METH resulted in increased immobility times in the forced swimming test (FST) and tail suspension test (TST) and led to depression-like behavior.

The production of reactive oxygen species (ROS) and apoptosis levels were increased in the VTA of animals in the METH-treated group.

METH downregulated Nrf2, HO-1, PI3K, and AKT, key factors of oxidative stress, and the apoptosis signaling pathway.

Moreover, METH increased the caspase-3 immunocontent.

These changes were reversed by treatment with the antioxidant TBHQ.

The results indicate that TBHQ can enhance Nrf2-induced antioxidative stress and PI3K-induced antiapoptotic effects, which can alleviate METH-induced ROS and apoptosis, and that the crosstalk between Nrf2 and PI3K/AKT is likely the key factor involved in the protective effect of TBHQ against METH-induced chronic nervous system toxicity.